Sakys John 4

What Happened

• John Sakys, Chief Financial Officer of Mesa Laboratories (MLAB), sold 1,223 shares on June 16, 2026, at $101.27 per share, generating proceeds of about $123,850. The Form 4 reports the sale as an open-market/private sale (code S) and was disclosed the next day (filed June 17, 2026).
• This sale was used to cover required taxes related to RSUs that vested on June 15, 2026, per the filing footnote; such tax-withholding sales are routine and do not necessarily indicate a change in the insider’s view of the company.

Key Details

• Transaction date: 2026-06-16; sale price: $101.27 per share; total proceeds ≈ $123,850.
• Transaction type: Sale (S) — open-market/private sale to cover taxes (footnote F1).
• Shares owned after transaction: Not specified in the provided filing.
• Notable footnotes: F1 — shares sold to cover taxes from RSU vesting on 2026-06-15; F2 — 50 shares held by Mr. Sakys as custodian for his children.
• Filing: Reported on 2026-06-17 (timely disclosure).

Context

• Tax-withholding sales tied to RSU vesting are common; they convert vested shares to cash for tax obligations and are generally considered routine rather than a directional signal about company prospects.
• For retail investors, purchases by insiders tend to be more informative than routine sales; use this sale as a record of compensation-related activity rather than evidence of insider bearishness.